SEC recommends phase 1 clinical trials of Reliance’s 2-dose Covid-19 vaccine
The Subject Expert Committee (SEC) has recommended phase 1 clinical trials of Reliance Life Sciences’ vaccine candidate against the coronavirus disease (Covid-19), press agency ANI reported on Friday. The proposed…